Jennifer Matsuda
Concepts (324)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Killer Cells, Natural | 18 | 2018 | 467 | 1.870 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 15 | 2024 | 331 | 1.160 |
Why?
| | Antigens, CD1 | 11 | 2008 | 60 | 1.000 |
Why?
| | Natural Killer T-Cells | 7 | 2016 | 67 | 0.950 |
Why?
| | T-Lymphocyte Subsets | 8 | 2022 | 415 | 0.890 |
Why?
| | Antigens, CD1d | 15 | 2018 | 68 | 0.790 |
Why?
| | Cell Differentiation | 10 | 2018 | 2048 | 0.600 |
Why?
| | Galactosylceramides | 9 | 2010 | 27 | 0.570 |
Why?
| | Mice | 44 | 2026 | 18329 | 0.490 |
Why?
| | Transcription Activator-Like Effector Nucleases | 1 | 2016 | 6 | 0.490 |
Why?
| | Mice, Inbred C57BL | 28 | 2025 | 5988 | 0.480 |
Why?
| | Cell Movement | 5 | 2020 | 965 | 0.480 |
Why?
| | T-Lymphocytes | 8 | 2025 | 1982 | 0.460 |
Why?
| | Th1 Cells | 2 | 2007 | 139 | 0.430 |
Why?
| | Lymphocyte Activation | 8 | 2022 | 1126 | 0.420 |
Why?
| | Animals | 51 | 2026 | 38030 | 0.400 |
Why?
| | Antigen Presentation | 4 | 2018 | 205 | 0.400 |
Why?
| | Thymus Gland | 7 | 2024 | 311 | 0.360 |
Why?
| | Colitis | 3 | 2025 | 280 | 0.340 |
Why?
| | CD4-Positive T-Lymphocytes | 7 | 2026 | 1128 | 0.340 |
Why?
| | Immune Tolerance | 2 | 2025 | 379 | 0.320 |
Why?
| | Mice, Knockout | 14 | 2025 | 3119 | 0.320 |
Why?
| | Major Histocompatibility Complex | 2 | 2024 | 229 | 0.320 |
Why?
| | T-Box Domain Proteins | 3 | 2007 | 106 | 0.310 |
Why?
| | Models, Immunological | 2 | 2007 | 100 | 0.310 |
Why?
| | Histocompatibility Antigens Class II | 3 | 2016 | 364 | 0.310 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 4 | 2012 | 21 | 0.300 |
Why?
| | Interferon-gamma | 4 | 2015 | 784 | 0.290 |
Why?
| | Antigens | 5 | 2020 | 347 | 0.280 |
Why?
| | Lymphocyte Subsets | 2 | 2005 | 83 | 0.270 |
Why?
| | Fibroblasts | 2 | 2026 | 1032 | 0.260 |
Why?
| | Mutation | 4 | 2020 | 4085 | 0.260 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 2 | 2022 | 100 | 0.250 |
Why?
| | Inflammation | 5 | 2025 | 2877 | 0.230 |
Why?
| | Gene Expression Regulation | 4 | 2013 | 2603 | 0.230 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2025 | 27 | 0.230 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 2 | 2026 | 240 | 0.220 |
Why?
| | Colon | 2 | 2025 | 304 | 0.220 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 37 | 0.220 |
Why?
| | C-Peptide | 1 | 2026 | 186 | 0.220 |
Why?
| | Th17 Cells | 1 | 2025 | 100 | 0.210 |
Why?
| | HLA-DRB1 Chains | 1 | 2025 | 109 | 0.210 |
Why?
| | Adipocytes | 2 | 2023 | 223 | 0.210 |
Why?
| | Autoantigens | 2 | 2011 | 429 | 0.200 |
Why?
| | Genes, T-Cell Receptor alpha | 1 | 2003 | 11 | 0.200 |
Why?
| | Catecholamines | 1 | 2023 | 87 | 0.200 |
Why?
| | NADPH Oxidases | 1 | 2024 | 124 | 0.200 |
Why?
| | Phagocytes | 1 | 2024 | 81 | 0.200 |
Why?
| | Interleukin-4 | 2 | 2003 | 206 | 0.190 |
Why?
| | Methionine | 1 | 2024 | 162 | 0.190 |
Why?
| | Transcription Factors | 3 | 2005 | 1739 | 0.190 |
Why?
| | Glutamic Acid | 1 | 2025 | 251 | 0.190 |
Why?
| | Antigens, Differentiation, B-Lymphocyte | 1 | 2002 | 37 | 0.190 |
Why?
| | Th2 Cells | 1 | 2003 | 171 | 0.180 |
Why?
| | Collagen | 1 | 2025 | 455 | 0.180 |
Why?
| | Lung Injury | 1 | 2025 | 237 | 0.180 |
Why?
| | Interleukin-15 | 1 | 2002 | 97 | 0.180 |
Why?
| | Dendritic Cells | 3 | 2020 | 499 | 0.180 |
Why?
| | Acute Lung Injury | 1 | 2025 | 302 | 0.180 |
Why?
| | Histone Deacetylases | 1 | 2023 | 210 | 0.180 |
Why?
| | Genes, T-Cell Receptor beta | 1 | 2001 | 23 | 0.180 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2023 | 220 | 0.180 |
Why?
| | Lipopolysaccharides | 1 | 2025 | 863 | 0.180 |
Why?
| | Cloning, Organism | 2 | 2002 | 7 | 0.170 |
Why?
| | Membrane Transport Proteins | 2 | 2000 | 154 | 0.170 |
Why?
| | Casein Kinase II | 1 | 2020 | 22 | 0.170 |
Why?
| | Dermis | 1 | 2020 | 32 | 0.160 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2026 | 691 | 0.160 |
Why?
| | Sertoli Cells | 1 | 2000 | 28 | 0.160 |
Why?
| | Listeriosis | 1 | 2020 | 65 | 0.160 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2020 | 22 | 0.160 |
Why?
| | Signal Transduction | 4 | 2020 | 5221 | 0.160 |
Why?
| | Apoptosis | 2 | 2026 | 2430 | 0.160 |
Why?
| | Mitochondrial Proteins | 2 | 2000 | 261 | 0.160 |
Why?
| | Immunity | 1 | 2020 | 139 | 0.150 |
Why?
| | Cellular Senescence | 2 | 2026 | 226 | 0.150 |
Why?
| | Listeria monocytogenes | 1 | 2020 | 116 | 0.150 |
Why?
| | Myeloid Cells | 1 | 2020 | 148 | 0.150 |
Why?
| | B-Lymphocytes | 2 | 2022 | 876 | 0.150 |
Why?
| | Intestinal Mucosa | 1 | 2025 | 676 | 0.150 |
Why?
| | Cryopreservation | 1 | 2000 | 110 | 0.150 |
Why?
| | Adipose Tissue | 3 | 2023 | 651 | 0.150 |
Why?
| | Cells, Cultured | 9 | 2020 | 4146 | 0.150 |
Why?
| | Lung | 6 | 2026 | 4108 | 0.140 |
Why?
| | Mice, Transgenic | 7 | 2025 | 2182 | 0.140 |
Why?
| | Respiratory Hypersensitivity | 2 | 2010 | 65 | 0.140 |
Why?
| | Mice, Inbred BALB C | 5 | 2018 | 1253 | 0.140 |
Why?
| | Glycolipids | 2 | 2018 | 52 | 0.140 |
Why?
| | B7-H1 Antigen | 1 | 2020 | 241 | 0.140 |
Why?
| | Immunologic Memory | 1 | 2020 | 366 | 0.140 |
Why?
| | Thiazoles | 1 | 1998 | 135 | 0.140 |
Why?
| | Carrier Proteins | 2 | 2000 | 736 | 0.140 |
Why?
| | Thiazolidinediones | 1 | 1998 | 138 | 0.130 |
Why?
| | Disease Models, Animal | 6 | 2026 | 4556 | 0.130 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 479 | 0.130 |
Why?
| | Autoimmunity | 2 | 2020 | 924 | 0.130 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2026 | 3842 | 0.130 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2016 | 40 | 0.120 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2016 | 41 | 0.120 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2016 | 388 | 0.120 |
Why?
| | Down Syndrome | 1 | 2023 | 534 | 0.120 |
Why?
| | Lipids | 1 | 2001 | 700 | 0.120 |
Why?
| | Arthritis, Rheumatoid | 1 | 2025 | 1168 | 0.120 |
Why?
| | Epithelial Cells | 3 | 2020 | 1125 | 0.110 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 913 | 0.110 |
Why?
| | Insulin | 1 | 2026 | 2501 | 0.110 |
Why?
| | Pseudomonas Infections | 1 | 2016 | 221 | 0.110 |
Why?
| | Pseudomonas aeruginosa | 1 | 2016 | 356 | 0.100 |
Why?
| | Interleukins | 1 | 2015 | 248 | 0.100 |
Why?
| | Cytokines | 3 | 2025 | 2061 | 0.090 |
Why?
| | Ovalbumin | 2 | 2010 | 190 | 0.090 |
Why?
| | Mice, Inbred NOD | 2 | 2026 | 610 | 0.090 |
Why?
| | Tuberculosis | 1 | 2015 | 289 | 0.090 |
Why?
| | Mycobacterium tuberculosis | 1 | 2015 | 334 | 0.090 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2024 | 668 | 0.090 |
Why?
| | Actins | 2 | 2026 | 422 | 0.080 |
Why?
| | Adipose Tissue, Brown | 2 | 2023 | 59 | 0.080 |
Why?
| | Alleles | 2 | 2025 | 878 | 0.080 |
Why?
| | Retroviridae | 2 | 2013 | 101 | 0.080 |
Why?
| | Neutrophils | 1 | 2016 | 1134 | 0.080 |
Why?
| | Phosphorylation | 3 | 2020 | 1732 | 0.080 |
Why?
| | Lung Diseases | 1 | 2016 | 787 | 0.080 |
Why?
| | Lymph Nodes | 3 | 2020 | 502 | 0.080 |
Why?
| | Proteins | 3 | 2000 | 1021 | 0.080 |
Why?
| | Smoking | 1 | 2016 | 1468 | 0.070 |
Why?
| | Macrophages | 1 | 2016 | 1510 | 0.070 |
Why?
| | NK Cell Lectin-Like Receptor Subfamily B | 2 | 2015 | 9 | 0.070 |
Why?
| | Antigens, Ly | 2 | 2015 | 40 | 0.070 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2008 | 223 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2020 | 917 | 0.070 |
Why?
| | Humans | 15 | 2026 | 144261 | 0.070 |
Why?
| | Receptors, CXCR3 | 1 | 2007 | 16 | 0.060 |
Why?
| | Receptors, Chemokine | 1 | 2007 | 47 | 0.060 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2007 | 24 | 0.060 |
Why?
| | Estrogen Antagonists | 1 | 2007 | 48 | 0.060 |
Why?
| | Allergens | 1 | 2010 | 384 | 0.060 |
Why?
| | Complementarity Determining Regions | 2 | 2007 | 53 | 0.060 |
Why?
| | RNA, Messenger | 4 | 2003 | 2829 | 0.060 |
Why?
| | Tamoxifen | 1 | 2007 | 217 | 0.060 |
Why?
| | Cathepsin D | 1 | 2026 | 19 | 0.060 |
Why?
| | Molecular Sequence Data | 2 | 2001 | 2929 | 0.060 |
Why?
| | Sphingomyelins | 1 | 2025 | 22 | 0.060 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2026 | 54 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2009 | 698 | 0.060 |
Why?
| | Lymphopenia | 2 | 2002 | 65 | 0.060 |
Why?
| | Sphingolipids | 1 | 2025 | 83 | 0.050 |
Why?
| | Cell Survival | 2 | 2005 | 1098 | 0.050 |
Why?
| | Ceramides | 1 | 2025 | 116 | 0.050 |
Why?
| | Myofibroblasts | 1 | 2026 | 143 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 981 | 0.050 |
Why?
| | Skin Transplantation | 1 | 2025 | 85 | 0.050 |
Why?
| | Amino Acid Sequence | 2 | 2016 | 2154 | 0.050 |
Why?
| | Homeostasis | 3 | 2004 | 640 | 0.050 |
Why?
| | Anaerobiosis | 1 | 2024 | 64 | 0.050 |
Why?
| | Uncoupling Protein 1 | 1 | 2023 | 17 | 0.050 |
Why?
| | Receptors, Estrogen | 1 | 2007 | 457 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2025 | 304 | 0.050 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2026 | 279 | 0.050 |
Why?
| | Receptors, Interleukin-12 | 1 | 2003 | 6 | 0.050 |
Why?
| | Bone Marrow Transplantation | 1 | 2025 | 294 | 0.050 |
Why?
| | Thermogenesis | 1 | 2023 | 45 | 0.050 |
Why?
| | Receptors, Interleukin | 1 | 2003 | 43 | 0.050 |
Why?
| | Heterozygote | 1 | 2024 | 315 | 0.050 |
Why?
| | Crosses, Genetic | 1 | 2003 | 124 | 0.050 |
Why?
| | Immunity, Innate | 3 | 2016 | 846 | 0.050 |
Why?
| | Crystallography, X-Ray | 2 | 2018 | 492 | 0.050 |
Why?
| | Respiration | 1 | 2024 | 206 | 0.050 |
Why?
| | Receptors, Interferon | 1 | 2023 | 60 | 0.050 |
Why?
| | Interleukin-10 | 2 | 2002 | 309 | 0.050 |
Why?
| | Immunophenotyping | 2 | 2001 | 322 | 0.050 |
Why?
| | CD40 Antigens | 1 | 2003 | 90 | 0.050 |
Why?
| | Uncoupling Protein 3 | 2 | 2000 | 9 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1054 | 0.050 |
Why?
| | Uncoupling Protein 2 | 2 | 2000 | 9 | 0.050 |
Why?
| | Female | 7 | 2026 | 77976 | 0.050 |
Why?
| | Interleukin-7 | 1 | 2002 | 65 | 0.050 |
Why?
| | Salmonella typhimurium | 1 | 2024 | 190 | 0.050 |
Why?
| | Clonal Anergy | 1 | 2022 | 54 | 0.040 |
Why?
| | Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2001 | 27 | 0.040 |
Why?
| | Interleukin-17 | 1 | 2022 | 118 | 0.040 |
Why?
| | Interferons | 1 | 2023 | 188 | 0.040 |
Why?
| | Ion Channels | 2 | 2000 | 129 | 0.040 |
Why?
| | Carbohydrate Sequence | 1 | 2001 | 28 | 0.040 |
Why?
| | Insulin-Secreting Cells | 1 | 2026 | 387 | 0.040 |
Why?
| | Protein Conformation | 2 | 2018 | 946 | 0.040 |
Why?
| | Antigens, Protozoan | 1 | 2001 | 32 | 0.040 |
Why?
| | Antigens, Fungal | 1 | 2001 | 28 | 0.040 |
Why?
| | Chemokine CCL21 | 1 | 2020 | 13 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 2 | 2004 | 420 | 0.040 |
Why?
| | Organ Specificity | 1 | 2001 | 312 | 0.040 |
Why?
| | Receptors, CCR7 | 1 | 2020 | 31 | 0.040 |
Why?
| | Cell Division | 1 | 2002 | 766 | 0.040 |
Why?
| | Lymphotoxin-alpha | 1 | 2000 | 6 | 0.040 |
Why?
| | Poly I-C | 1 | 2020 | 57 | 0.040 |
Why?
| | Nuclear Transfer Techniques | 1 | 2000 | 5 | 0.040 |
Why?
| | Pseudopregnancy | 1 | 2000 | 4 | 0.040 |
Why?
| | Lectins, C-Type | 1 | 2000 | 62 | 0.040 |
Why?
| | Lymphatic System | 1 | 2020 | 16 | 0.040 |
Why?
| | Embryonic and Fetal Development | 1 | 2000 | 93 | 0.040 |
Why?
| | Intestine, Large | 1 | 2000 | 14 | 0.040 |
Why?
| | Antigens, Surface | 1 | 2000 | 157 | 0.040 |
Why?
| | Embryo Transfer | 1 | 2000 | 37 | 0.040 |
Why?
| | Dimerization | 1 | 2000 | 193 | 0.040 |
Why?
| | Antigens, Bacterial | 1 | 2001 | 125 | 0.040 |
Why?
| | Mice, Inbred DBA | 1 | 2000 | 187 | 0.040 |
Why?
| | Chemotaxis | 1 | 2020 | 122 | 0.040 |
Why?
| | GTP-Binding Proteins | 1 | 2020 | 153 | 0.040 |
Why?
| | Cell Count | 1 | 2020 | 320 | 0.040 |
Why?
| | Leukocyte Common Antigens | 1 | 2000 | 88 | 0.040 |
Why?
| | Polymerization | 1 | 2020 | 130 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 173 | 0.040 |
Why?
| | Bone Marrow Cells | 3 | 2010 | 320 | 0.040 |
Why?
| | CD4 Antigens | 1 | 2000 | 139 | 0.040 |
Why?
| | Clone Cells | 1 | 2000 | 266 | 0.040 |
Why?
| | Epitopes | 1 | 2001 | 485 | 0.040 |
Why?
| | Exons | 1 | 2020 | 358 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2026 | 832 | 0.040 |
Why?
| | Oocytes | 1 | 2000 | 178 | 0.040 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2000 | 253 | 0.040 |
Why?
| | Mice, SCID | 1 | 2000 | 369 | 0.040 |
Why?
| | Protein Domains | 1 | 2020 | 313 | 0.040 |
Why?
| | Transgenes | 2 | 2015 | 189 | 0.040 |
Why?
| | Bleomycin | 1 | 2020 | 253 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2005 | 1782 | 0.040 |
Why?
| | DNA Repair | 1 | 2020 | 255 | 0.030 |
Why?
| | Immunoglobulin Variable Region | 2 | 2012 | 80 | 0.030 |
Why?
| | Spleen | 1 | 2000 | 508 | 0.030 |
Why?
| | Cell Cycle | 1 | 2020 | 596 | 0.030 |
Why?
| | Rats, Wistar | 1 | 1998 | 451 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2001 | 525 | 0.030 |
Why?
| | Bacteriolysis | 1 | 2016 | 10 | 0.030 |
Why?
| | Base Sequence | 1 | 2020 | 2187 | 0.030 |
Why?
| | Glucose | 2 | 2000 | 1046 | 0.030 |
Why?
| | Smad1 Protein | 1 | 2016 | 17 | 0.030 |
Why?
| | Activin Receptors, Type II | 1 | 2016 | 12 | 0.030 |
Why?
| | Amino Acids | 1 | 2020 | 521 | 0.030 |
Why?
| | Peroxidase | 1 | 2016 | 168 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2018 | 402 | 0.030 |
Why?
| | Germ Cells | 1 | 2016 | 66 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2013 | 1172 | 0.030 |
Why?
| | Male | 6 | 2026 | 72035 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 336 | 0.030 |
Why?
| | RNA Splice Sites | 1 | 2015 | 50 | 0.030 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2015 | 45 | 0.030 |
Why?
| | CRISPR-Cas Systems | 1 | 2016 | 170 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 3157 | 0.030 |
Why?
| | Cloning, Molecular | 2 | 2009 | 539 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2022 | 1519 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2879 | 0.030 |
Why?
| | Early Growth Response Protein 2 | 1 | 2013 | 10 | 0.030 |
Why?
| | Virulence | 1 | 2015 | 278 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2020 | 1495 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2020 | 869 | 0.030 |
Why?
| | Thymocytes | 1 | 2013 | 34 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2000 | 1165 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2015 | 169 | 0.030 |
Why?
| | Surface Plasmon Resonance | 1 | 2013 | 89 | 0.020 |
Why?
| | Rats | 2 | 2000 | 5592 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2020 | 2494 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 1998 | 2525 | 0.020 |
Why?
| | Transfection | 1 | 2015 | 938 | 0.020 |
Why?
| | Immune System | 1 | 2013 | 179 | 0.020 |
Why?
| | Energy Metabolism | 1 | 1998 | 935 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2015 | 368 | 0.020 |
Why?
| | Muscle, Skeletal | 2 | 2000 | 1792 | 0.020 |
Why?
| | Hypertension | 1 | 2000 | 1254 | 0.020 |
Why?
| | Receptors, Natural Killer Cell | 1 | 2011 | 16 | 0.020 |
Why?
| | Stroke | 1 | 2000 | 1254 | 0.020 |
Why?
| | Peptides | 1 | 2016 | 995 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1217 | 0.020 |
Why?
| | Protein Binding | 1 | 2016 | 2270 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2010 | 198 | 0.020 |
Why?
| | Bronchial Hyperreactivity | 1 | 2010 | 96 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2011 | 172 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2010 | 246 | 0.020 |
Why?
| | Crystallization | 1 | 2009 | 145 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2013 | 1255 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 1998 | 1379 | 0.020 |
Why?
| | Mutagenesis | 1 | 2009 | 190 | 0.020 |
Why?
| | Ligands | 1 | 2010 | 673 | 0.020 |
Why?
| | Crystallography | 1 | 2007 | 28 | 0.020 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2007 | 14 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2007 | 11 | 0.020 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2007 | 18 | 0.020 |
Why?
| | Receptors, Retinoic Acid | 1 | 2007 | 42 | 0.020 |
Why?
| | Intubation, Intratracheal | 1 | 2010 | 320 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2010 | 508 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 299 | 0.020 |
Why?
| | Pregnancy | 1 | 2000 | 7180 | 0.020 |
Why?
| | Models, Molecular | 1 | 2011 | 1618 | 0.010 |
Why?
| | Precipitin Tests | 1 | 2004 | 93 | 0.010 |
Why?
| | CpG Islands | 1 | 2004 | 165 | 0.010 |
Why?
| | Organ Culture Techniques | 1 | 2003 | 154 | 0.010 |
Why?
| | Time Factors | 1 | 2013 | 7155 | 0.010 |
Why?
| | Stromal Cells | 1 | 2003 | 124 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2004 | 758 | 0.010 |
Why?
| | Immunoglobulin Joining Region | 1 | 2001 | 10 | 0.010 |
Why?
| | Liver | 1 | 2010 | 1884 | 0.010 |
Why?
| | Rats, Inbred WKY | 1 | 2000 | 37 | 0.010 |
Why?
| | Epididymis | 1 | 2000 | 14 | 0.010 |
Why?
| | Rats, Inbred SHR | 1 | 2000 | 37 | 0.010 |
Why?
| | Lymphotoxin-beta | 1 | 2000 | 1 | 0.010 |
Why?
| | Lymphotoxin beta Receptor | 1 | 2000 | 2 | 0.010 |
Why?
| | bcl-X Protein | 1 | 2000 | 45 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2000 | 204 | 0.010 |
Why?
| | Injections, Intraperitoneal | 1 | 2000 | 116 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 2000 | 200 | 0.010 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2000 | 41 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 163 | 0.010 |
Why?
| | Cell Lineage | 1 | 2001 | 376 | 0.010 |
Why?
| | Carbohydrate Conformation | 1 | 1998 | 15 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2000 | 292 | 0.010 |
Why?
| | Hybridomas | 1 | 1998 | 234 | 0.010 |
Why?
| | Antigen-Presenting Cells | 1 | 1998 | 160 | 0.010 |
Why?
| | Lymphoma, B-Cell | 1 | 1998 | 132 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 1998 | 567 | 0.010 |
Why?
| | Stem Cells | 1 | 2001 | 625 | 0.010 |
Why?
| | HeLa Cells | 1 | 1998 | 650 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1998 | 919 | 0.010 |
Why?
| | Aged | 1 | 2016 | 25850 | 0.010 |
Why?
| | Gene Expression | 1 | 2000 | 1487 | 0.010 |
Why?
| | Myocardium | 1 | 2000 | 939 | 0.010 |
Why?
| | Middle Aged | 1 | 2016 | 35762 | 0.010 |
Why?
| | Aging | 1 | 2002 | 1964 | 0.010 |
Why?
|
|
Matsuda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|